Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-[131I]iodo-L-phenylalanine |
---|---|
Date Designated: | 01/04/2011 |
Orphan Designation: | Treatment of glioma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Telix Pharmaceuticals (US) Inc. 10475 Crosspoint Boulevard Suite 250 Indianapolis, Indiana 46256 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-